Related Experiment Video
Updated: Jul 31, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
"Do-it-yourself" dementia testing: issues regarding an Alzheimer's home screening test.
Frederick J Kier1, Victor Molinari
1VA Pittsburgh Healthcare System, PA 15206, USA. frederick.kier@med.va.gov
The Gerontologist
|June 18, 2003
Summary
The Early Alert Alzheimer's Home Screening Test (AHST) may not be valid for detecting asymptomatic cognitive impairment. Its use raises concerns due to potential misinterpretation and misuse by the public and physicians.
Area of Science:
- Neurology
- Gerontology
- Public Health
Background:
- The Early Alert Alzheimer's Home Screening Test (AHST), a variant of smell identification tests, is now available to the public.
- The utility of routine screening for asymptomatic cognitive impairment using AHST is not established.
- Olfactory impairment is associated with aging, medical conditions, and lifestyle factors, independent of cognitive status.
Purpose of the Study:
- To evaluate the validity and practical utility of the AHST for routine screening of asymptomatic cognitive impairment.
- To identify methodological concerns and potential for misuse of the AHST in the general public and clinical settings.
Main Methods:
- Review of existing literature and methodological concerns regarding the AHST.
- Analysis of the association between olfactory impairment and non-cognitive factors (age, medical conditions, lifestyle).
- Examination of potential public and physician misunderstandings and misuse scenarios.
Main Results:
- The validity and utility of AHST for detecting asymptomatic cognitive impairment are not established.
- Olfactory impairment is linked to age, medical conditions, and lifestyle, complicating interpretation.
- Potential for public misunderstanding of screening vs. diagnostic tests and physician confusion regarding follow-up exists.
Conclusions:
- The marketing and widespread use of AHST without adequate public health education are inappropriate and potentially unethical.
- Concerns regarding test validity, interpretation, and misuse necessitate caution.
- Further research and educational safeguards are needed before public use of AHST.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...